Already registered? Access the conference here.
The Advances in Antibacterial Discovery symposium will take place on Friday, December 3, 2021. The meeting will discuss the latest advances in the antibacterial drug discovery field. The symposium features talks from leading researchers and their trainees selected from recent high-profile publications. Opportunities for attendee interaction will be made available on the conference website.
This virtual symposium, hosted by the St. Jude Department of Chemical Biology and Therapeutics, is a part of the broader Bringing Chemistry to Medicine series and is supported by the St. Jude T32 Infectious Disease Therapeutics training program.
Registration is free to facilitate participation and interaction among trainees and scientists around the world.
Speakers to include:
Heike Brotz-Oesterhelt, PhD
University of Tuebingen
Christoph Ernst, PhD
Deborah Hung Lab, Broad Institute, Harvard Medical School, Massachusetts General Hospital
Kristina Klobucar
Eric Brown Lab, McMaster University
Paul J. Hergenrother PhD
University of Illinois
Kim Lewis, PhD
Northeastern University
Alita A. Miller, PhD
Entasis Therapeutics
Stephanie M. Reeve, PhD
Richard Lee Lab, St. Jude Children's Research Hospital
Jeremy Rock, PhD
Rockefeller University
Jickky Palmae Sarathy, PhD
Thomas Dick Lab, Center for Discovery and Innovation, Hackensack Meridian Health
Jonathan Stokes, PhD
McMaster University
Agenda
(All times are Central)
| Session | Speaker |
|---|---|
| Opening Remarks | |
| 8:15-8:30 am | Richard Lee, PhD |
| Novel Approaches to Antimicrobial Drug Discovery | |
| 8:30-9:00 am | Alita A. Miller, PhD |
| 9:00-9:30 am | Heike Brotz-Oesterhelt, PhD |
| 9:30-9:40 am | Break |
| Understanding Challenges of Permeability in Gram-negative Pathogens | |
| 9:40-10:10 am | Paul J. Hergenrother, PhD |
| 10:10-10:35 am | Kristina Klobucar |
| 10:35-11:00 am | Stephanie M. Reeve, PhD |
| Networking, posters, lunch, etc | |
| 11:00am-12:00 pm | Networking, posters, lunch, etc |
| Keynote/Danny Thomas Lecture Series | |
| 12:00-1:00 pm | Kim Lewis, PhD |
| Novel Chemical Matter to Combat Antimicrobial Resistance | |
| 1:00-1:30 pm | Jonathan Stokes, PhD |
| 1:30-2:00 pm | Christoph Ernst, PhD |
| 2:00-2:15 pm | Break |
| Developments in M. Tuberculosis Drug Discovery | |
| 2:15-2:45 pm | Jeremy Rock, PhD |
| 2:45-3:15 pm | Jickky Palme Sarathy, PhD |
| 3:15-3:45 pm | Virtual Happy Hour and Round Table Discussion |
| 3:45-4:00 pm | Closing remarks |
About Chemical Biology and Therapeutics
The Chemical Biology and Therapeutics (CBT) Department formulates innovative chemical and chemoinformatic solutions to resolve salient problems in biology and medicine. Fundamental research programs to uncover underlying biological processes are complemented by translational centers that house chemical synthesis, screening, and computational capabilities that mirror cutting-edge biotech/pharma operations, resources rarely accessible at academic institutions.
The expertise and resources of CBT are leveraged across the institution, making it a highly dynamic and diverse collaborative hub at St. Jude. The scientific research arm of CBT is in an exciting growth phase; individuals with bold vision and demonstrated excellence in research at the interface of Chemistry, Biology, and Medicine are encouraged to join the team.